AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of July 24, 2026, AEON stock price declined to $0.25 with 254,612 million shares trading.

AEON has a beta of -0.40, meaning it tends to be less sensitive to market movements. AEON has a correlation of 0.00 to the broad based SPY ETF.

AEON has a market cap of $11.07 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AEON traded as high as $1,236.24 and as low as $.24.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has underperformed the market in the last year with a price return of -69.1% while the SPY ETF gained +17.7%. AEON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -76.1% and -48.1%, respectively, while the SPY returned +3.8% and -2.1%, respectively.

AEON support price is $.24 and resistance is $.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.